Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Clinical Research and Public HealthIn-Press PreviewImmunologyInfectious disease Open Access | 10.1172/jci.insight.199941

Th2 skewing in patients with disseminated coccidioidomycosis

Timothy J. Thauland,1 Smriti S. Nagarajan,1 Alexis V. Stephens,2 Samantha L. Jensen,2 Anviksha Srivastava,1 Miguel A. Moreno Lastre,1 Terrie S. Ahn,1 Chantana Bun,1 Michael T. Trump,1 Royce H. Johnson,3 George R. Thompson III,4 Maria I. Garcia-Lloret,1 Valerie A. Arboleda,5 and Manish J. Butte1

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Thauland, T. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Nagarajan, S. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Stephens, A. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Jensen, S. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Srivastava, A. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Moreno Lastre, M. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Ahn, T. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Bun, C. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Trump, M. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Johnson, R. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Thompson III, G. in: PubMed | Google Scholar |

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Garcia-Lloret, M. in: PubMed | Google Scholar

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Arboleda, V. in: PubMed | Google Scholar |

1Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, United States of America

2Department of Human Genetics, UCLA, Los Angeles, United States of America

3Valley Fever Institute, Kern Medical, Bakersfield, United States of America

4Department of Medicine, Division of Infectious Diseases, UCD, Davis, United States of America

5Department of Microbiology Immunology and Molecular Genetics, UCLA, Los Angeles, United States of America

6Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los angeles, United States of America

Find articles by Butte, M. in: PubMed | Google Scholar |

Published April 21, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.199941.
Copyright © 2026, Thauland et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 21, 2026 - Version history
View PDF
Abstract

BACKGROUND. Disseminated coccidioidomycosis (DCM) is an often fatal and otherwise intractable condition requiring lifelong antifungal treatment. We have previously shown that a deranged polarization of CD4+ T cells toward a Th2 phenotype can exist in the context of DCM. Here we studied a large population of subjects to determine the frequency of abnormal Th2 skewing of CD4+ T cells in patients with coccidioidomycosis and to identify underlying genetic mechanisms supporting this phenotype.

METHODS. We collected peripheral blood mononuclear cells from 204 patients with coccidioidomycosis, including 96 patients with disseminated disease. We measured immune phenotypes and cytokine production by CD4+ T cells from patients and healthy controls, and comparisons between groups were made based on disease severity and demographics. Whole genome sequencing was conducted on 180 individuals who also had cytokine profiling.

RESULTS. We found that ~25% of DCM patients had a CD4+ T-cell compartment that was abnormally skewed toward a Th2 phenotype, and Th2 skewing was highly correlated with male sex. Co-culture of T cells with the IL4R/IL13R-blocking antibody dupilumab reduced Th2 skewing. Sequencing revealed rare variants in genes involved in the IL-12-IFN-γ axis in several Th2-skewed patients, and we validated one such variant in IFNGR1 as hypomorphic.

CONCLUSION. Patients with DCM, especially males, should be screened for Th2 skewing of CD4+ T cells. Patients with Th2 skewing should be additionally screened for genetic defects in the IL-12-IFN-γ axis. Our findings give a mechanistic rationale for blockade of IL4R in Th2-skewed patients with refractory coccidioidomycosis.

Supplemental material

View

Version history
  • Version 1 (April 21, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts